scorecardresearch
Add as a preferred source on Google
Sunday, April 19, 2026
TopicCDSCO

Topic: CDSCO

Govt planning regulatory sandboxes for pharma sector to fast-track approvals & drug development

On the sidelines of the Bio Asia event in Hyderabad, BIRAC MD Jitendra Kumar says biotechnology department is planning the sandboxes to 'reduce regulatory uncertainty'.

Health ministry eases drug trial rules. Test licences scrapped, CDSCO approval timelines cut by half

Under earlier rules, drugmakers had to get a test licence from CDSCO to manufacture small quantities of drugs for research, examination or analysis.

Use nimesulide only after exhausting first-line options—expert panel under drug regulator CDSCO

Last year, an ICMR panel even considered recommending all-India ban on popular painkiller amid concerns it could cause liver damage, which could turn life-threatening in some cases.

As CDSCO lifts suspension on eye drops designed to replace reading glasses, makers eye June launch

Doctors caution that the drug should be used only under strong and regular supervision of an ophthalmologist.

No local clinical trial waiver despite change in rules, drugmakers knock on health ministry’s door

Drug regulator through executive order issued last August paved way for direct launch of certain categories of drugs approved in select countries by means of local clinical trials waiver.

Antibiotics launched in India will soon need CDSCO nod as drug resistance emerges as silent killer

In 2019, bacterial antimicrobial resistance killed between 3 lakh and 10.4 lakh people in India, according to a Lancet report.

Why a govt-appointed panel has recommended a complete ban on popular painkiller nimesulide

First launched in Italy in 1985, Nimesulide is available in India under brand names like Nimuwin, Nimutab, Nimopen, Nisulid, Nimdase, Nodard Plus, Nicip, Nimcap, Nicip-P and Nimupain.

Govt says no plan to ban heartburn drug ranitidine, carcinogenic impurities within safe limits

In 2019, evidence showed that an impurity in drug degrades over time to form probable carcinogenic compound. Ranitidine is sold as heartburn medicine under names Rantac, Aciloc & Zinetac.

Drug regulator considers making central nod mandatory for all antibiotics in India, even existing ones

This new proposal, being considered by CDSCO, comes in response to concerns over antimicrobial resistance emerging as a massive public health challenge across the globe, including in India.

India has a substandard, fake drugs problem. Lack of recall law, scrutiny is making matters worse

Underlining need for more accountability, experts also stress that govt data does not include fixed dose combination drugs, which account for over 40% of drugs sold in India.

On Camera

Indian influencers reclaim desi aesthetics at Coachella—jhumkas, dupattas to mehendi

By mixing Indian maximalism with Western minimalism, desi influencers are using the hippie Met Gala to bring about a quiet revolution in festival dressing.

Recovery of energy flows will be ‘gradual rather than immediate’ as Hormuz re-opens post ceasefire

The reopening of the Strait of Hormuz eases supply fears, but controlled shipping, slow output recovery, and high costs may delay oil flow normalisation for months.

Why Siliguri Corridor is strategically important for India & how it is being secured | Cut The Clutter

This special edition of Cut The Clutter, straight from the Siliguri corridor, details the strategic importance of the narrow strip of land in West Bengal, and how it’s a vital link connecting the Northeast to the rest of India.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.